13 results
10-Q
2020 Q3
ONCR
Oncorus, Inc.
12 Nov 20
Quarterly report
8:01am
, recall, seizure or total or partial suspension of product manufacture.
We are subject to multiple manufacturing risks, any of which could … of the products, product seizure, detention, or recall, operating restrictions, suits under the civil False Claims Act, corporate integrity agreements
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
, stock price and prospects. Some of these events could be the basis for FDA or other regulatory authority action, including injunction, recall, seizure … seizure, detention, or recall, operating restrictions, suits under the civil False Claims Act, corporate integrity agreements, consent decrees
DRS/A
ONCR
Oncorus, Inc.
20 Dec 19
Draft registration statement (amended)
12:00am
and prospects. Some of these events could be the basis for FDA or other regulatory authority action, including injunction, recall, seizure or total … , product seizure, detention, or recall, operating restrictions, suits under the civil False Claims Act, corporate integrity agreements, consent decrees
DRS/A
bvvnpa b9f
26 Aug 20
Draft registration statement (amended)
12:00am
S-1
y6d6thg8ul dl7yp
11 Sep 20
IPO registration
4:49pm
424B4
9aco i8xw
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
atsr kmbvo0osqgxl
31 Oct 19
Draft registration statement
12:00am
DRS
htqppm8i l2x
28 Jan 21
Draft registration statement
12:00am
DRS/A
eoehpyqer6i0ozkho7
29 Jul 20
Draft registration statement (amended)
12:00am
424B4
94up1cqhq75zexbkycb
2 Oct 20
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next